T23967 |
BPHA |
源葉(MedMol) | 98% |
- 產(chǎn)品描述:
BPHA 是一種有效的具有口服活性的 MMP-2、MMP-9 和 MMP-14 抑制劑,IC50 分別為 12 nM、16 nM 和 17 nM。BPHA 不抑制 MMP-1、-3 和 -7 (IC50 分別為 974、>1000 和 795 nM)。BPHA 具有抗血管生成和抗腫瘤作用。
- 靶點(diǎn): MMP-2:12 nM (IC50);MMP-9:16 nM (IC50);MMP
- 體外研究:
BPHA does not inhibit typical serine proteinases (neutrophil elastase, plasmin, trypsin, and chymotrypsin), cysteine proteinases (cathepsins B and L), aspartic proteinase (HIV-1 protease), or metalloproteinase (aminopeptidase M).
- 體內(nèi)研究:
Daily oral administration of 200 mg/kg BPHA in mice results in potent inhibition of tumor-induced angiogenesis, primary tumor growth, and liver metastasis. The growth inhibition activity of BPHA is 48% and 45% in a B16-BL6 melanoma and F2 hemangio-endothelioma model, respectively.
- 參考文獻(xiàn):
1. R Maekawa, et al. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res. 1999 Mar 15;59(6):1231-5.
- 保存條件: -20℃,密閉,干燥
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.522 ml 12.612 ml 25.223 ml 5 mM 0.504 ml 2.522 ml 5.045 ml 10 mM 0.252 ml 1.261 ml 2.522 ml 50 mM 0.05 ml 0.252 ml 0.504 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)